Efficacy of fludarabine, mitoxantrone, dexamethasone alternating with cyclophosphamide, doxorubicin, vincristine and prednisone (FMD/CHOP) in bulky follicular non-Hodgkin's lymphoma

被引：0
|
作者：
Wilder, DD
Ogden, JL
Jain, VK
机构：
[1] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[2] Texas Oncol PA, Dallas, TX USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2529
引用
收藏
页码：603A / 603A
页数：1
相关论文
共 50 条
  • [21] A Phase II Trial of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients with Previously Untreated Indolent Non-Hodgkin's Lymphoma
    Cohen, Jonathon B.
    Switchenko, Jeffrey
    Koff, Jean L.
    Sinha, Rajni
    Kaufman, Jonathan L.
    Khoury, H. Jean
    Bumpers, Nassoma K.
    Colbert, Amanda
    Hutchison-Rzepka, Amanda A.
    Nastoupil, Loretta J.
    Heffner, Leonard T.
    Langston, Amelia
    Lechowicz, Mary Jo
    Lonial, Sagar
    Flowers, Christopher R.
    BLOOD, 2014, 124 (21)
  • [22] Successful treatment of diffuse large B-cell non-Hodgkin lymphoma with modified CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy and rituximab in a patient with Nijmegen syndrome
    Dumic, Miroslav
    Radman, Ivo
    Krnic, Nevena
    Nola, Marin
    Kusec, Rajko
    Begovic, Davor
    Labar, Boris
    Rados, Marko
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (09) : 590 - 593
  • [23] MITOXANTRONE, ETOPOSIDE AND BLEOMYCIN (MEB) CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA PATIENTS NON-ELEGIBLE FOR STANDARD CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) COMBINATION
    TAGLIAFERRI, P
    MATANO, E
    REA, A
    FAMIANI, M
    CIARDIELLO, F
    TORTORA, G
    MONTESARCHIO, V
    MORABITO, A
    CARAGLIA, M
    DELAURENTIIS, M
    DEPLACIDO, S
    PALMIERI, G
    BIANCO, AR
    ONCOLOGY REPORTS, 1995, 2 (03) : 365 - 368
  • [24] COMBINATION CHEMOTHERAPY OF ADVANCED NON-HODGKIN LYMPHOMA WITH BLEOMYCIN, ADRIAMYCIN, CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE (BACOP)
    SKARIN, AT
    ROSENTHAL, DS
    MOLONEY, WC
    FREI, E
    BLOOD, 1977, 49 (05) : 759 - 770
  • [25] Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma
    Yau, JC
    Germond, C
    Gluck, S
    Cripps, C
    Verma, S
    Burns, BF
    Koski, TN
    Lister, DC
    Goss, GD
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 59 (02) : 156 - 160
  • [26] Dosis enhancement and biweekly administration of cyclophosphamide, vincristine, prednisone and doxorubicin or mitoxantrone, followed by stem cell transplantation: Results in non-Hodgkin's lymphomas of aggressive histology
    Capote, FJ
    Martin, MV
    Leon, A
    Fernandez, MC
    Jean-Paul, E
    Cos, C
    Rubio, V
    Lopez, R
    Correa, MA
    Gil, JL
    ANNALS OF ONCOLOGY, 1998, 9 : 113 - 113
  • [27] Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma
    Tinmouth, A
    Zanke, B
    Imrie, KR
    LEUKEMIA & LYMPHOMA, 2001, 41 (1-2) : 137 - 145
  • [28] Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicin- or mitoxantrone-containing regimen
    Gregory, SA
    Vose, J
    Modiano, M
    Kraemer, K
    Rifkin, R
    Rubin, A
    Menduni, T
    Ghalie, R
    LEUKEMIA & LYMPHOMA, 2001, 40 (3-4) : 315 - 324
  • [29] Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis
    Linschoten, Marijke
    Kamphuis, Janine A. M.
    Van Rhenen, Anna
    Bosman, Laurens P.
    Cramer, Maarten J.
    Doevendans, Pieter A.
    Teske, Arco J.
    Asselbergs, Folkert W.
    LANCET HAEMATOLOGY, 2020, 7 (04): : E295 - E308
  • [30] Achievement of molecular complete remissions in patients with bulky follicular lymphomas using alternating cycles of fludarabine, mitoxantrone, dexamethasone (FND) with chop chemotherapy.
    Jain, V
    Ogden, J
    Cooper, B
    Kimmel, G
    George, T
    BLOOD, 1996, 88 (10) : 1798 - 1798
12345